GnRH agonists in the treatment of symptomatic endometriosis: a reviewEssential Points
The development of highly potent gonadotropin-releasing hormone agonists (GnRHa) allowed for a significant addition to options for the medical management of symptomatic endometriosis. Pituitary GnRH receptor down-regulation leads to a hypogonadotropic and secondary hypoestrogenic state resulting in...
Saved in:
Main Author: | Eric S. Surrey, M.D (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020) -
A cumulative strategy of GnRH agonist, clomiphene citrate, and GnRH antagonist in a patient with recurrent endometriosis and repeated aspiration
by: Su-Long Lee, et al.
Published: (2011) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012) -
GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012) -
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
by: Raoul Orvieto
Published: (2023)